BioLargo Inc.
BioLargo Inc. is a billboard sponsor of Streetwise Reports and paid a fee for this company profile page. Please refer to the important disclosures below for additional details.
Recent Articles:
Clean Tech Co. Sees Record 80% Growth Through Q3
Pioneering Battery Technology Validates Performance for Long-Duration Energy Storage
Clean Tech Co. Takes 'Forever Chemicals' Solution to NY Conference
Cleantech Co. is Grossly Undervalued, Says Analyst
Cleantech Co. Increases Revenue, Cash Flow in Q2/24
Pet Odor Product Continues to Be Lucrative for Clean Tech Co.
More Articles
Expert Comments:
| "BioLargo Inc. delivered 247% year-over-year revenue growth in Q2/24, ahead of our estimates. Pooph revenue continues to grow rapidly, and the company's first PFAS remediation project is on track for completion by Q4/24. We are bullish on BioLargo's long-term prospects." | |
|
|
|
| "BioLargo Inc. announced Q2/24 revenues that again showed strong year-over-year and modest quarter-over-quarter growth. Revenues were $5M, up from $1.4M a year ago and up 5% sequentially as Pooph sales saw continued good performance." | |
|
|
|
| "BioLargo Inc. announced Q1/24 revenues that again showed strong year-over-year and quarter-over-quarter growth. The company generated positive cash flow from operations and increased its shareholders' equity to $5.1M, all while maintaining minimal debt and ending the quarter with $4.3M in cash." | |
|
|
|
| "The final PFAS regulations from the Environmental Protection Agency validate BioLargo Inc.'s water treatment vision. . .under the new rule, water utilities must monitor PFAS chemicals and would be required to notify the public and reduce contamination if levels exceeded the new standard. . .the large emerging market for PFAS removal and the company's growing validation in this opportunity should not be overlooked." | |
|
|
|
| "BioLargo Inc. announced that 2023 revenues more than doubled the level the company reported in 2022, making it the second year in a row that revenues have grown at that rate. BioLargo maintained gross margin at 50%, doubled shareholders' equity, all while maintaining minimal debt and ending the year with $3.5M in cash." | |
|
|
|
| "The fundamentals of BioLargo Inc. are superb with everything coming together in a positive manner after many years of work. So ultimately, the company's stock is believed headed much higher." | |
|
|
More Expert Comments
Experts Following This Company
| Clive Maund – CliveMaund.com | |
| Richard Ryan – Oak Ridge Financial | |
| Gowshihan Sriharan – Singular Research | |
 |
Chris Temple, Editor and Publisher – The National Investor |
Company News
11/15/2024 – BioLargo's Year-to-Date Revenues Up 80%
11/13/2024 – BioLargo Q3 2024 Earnings Results Webcast and Conference Call on Thursday, November 14, 2024 - 4:30 PM Eastern Time
10/14/2024 – BioLargo Validates Key Performance Metrics of Its Cellinity Battery Energy Storage Technology
10/14/2024 – BioLargo Validates Key Performance Metrics of Its Cellinity Battery Energy Storage Technology
9/16/2024 – BioLargo to Host Ribbon-Cutting Event for Battery Pilot Manufacturing Facility
Important Disclosures
BioLargo Inc. is a Billboard advertiser of Streetwise Reports and pays a flat fee. Fees fund both sponsor-specific activities and general report activities. Sponsor-specific activities may include aggregating content and publishing that content on the Streetwise Reports site, creating and maintaining company landing pages, interviewing key management, posting a banner/billboard, and/or issuing press releases.
The fees also cover the costs for Streetwise Reports to publish and syndicate investment opinion and comments, and also to curate or create sector-specific content.
Billboard advertising monthly fees range from $3,000 to $5,000.
This landing page contains a summary of the company that was prepared by that company.
Some landing pages contain investing highlights and a catalyst calendar that are prepared by that company.
The Expert Comments and Experts Following This Company sections of the landing page are compiled by Streetwise Reports.
There may be other information about the company that is not placed on the landing page, and Streetwise Reports does not guarantee the accuracy or thoroughness of the information contained on the landing page.
Readers should conduct their own research for all information publicly available concerning the company.
This landing page may be considered advertising for the purposes of 18 U.S.C. 1734.
Streetwise Company Fact Sheet2024/11/21 18:59:48
(BLGO:OTCQX)
Analyst coverage
| Oak Ridge Financial — Richard Ryan |
| Singular Research — Gowshihan Sriharan |
Newsletter coverage
| — |
| — |
Company News
| View Latest News |
Streetwise Reports Articles
| 11/18/2024 - View Article |
| 10/14/2024 - View Article |
| 09/13/2024 - View Article |
| 09/04/2024 - View Article |
| 08/23/2024 - View Article |
Streetwise - BioLargo Inc. Ownership Overview*
BioLargo Inc. (BLGO:OTCQB)
| Invest-prove-partner business model that leverages credible partners to maximize impact | |
| Unrivaled technologies to solve challenges in emerging environmental markets | |
| Heading toward profitability, with average QoQ revenue growth of +25% over past two years |
© 2024 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
